Excelsus Statistics

Montreal, Canada Founded: 2014 • Age: 12 yrs Acquired By Innovaderm
CRO focused on clinical development for dermatology drugs, site management, and patient recrutiment services

About Excelsus Statistics

Excelsus Statistics is a company based in Montreal (Canada) founded in 2014 was acquired by Innovaderm in July 2022.. Excelsus Statistics offers products and services including Dermatology Clinical Trials and Aesthetics Research. Excelsus Statistics operates in a competitive market with competitors including PPD, Cambrian BioPharma, Medicus Pharma, H.U. Group Holdings and DM Clinical, among others.

  • Headquarter Montreal, Canada
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    Innovaderm

    (Jul 05, 2022)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Excelsus Statistics

Excelsus Statistics offers a comprehensive portfolio of products and services, including Dermatology Clinical Trials and Aesthetics Research. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Conducts trials for skin conditions and treatments

Focuses on cosmetics and skin aging studies

Funding Insights of Excelsus Statistics

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Excelsus Statistics

Excelsus Statistics has secured backing from 1 investor. Prominent investors backing the company include Innovaderm. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Investor Description Founded Year Domain Location
Conducts clinical trials for dermatology research and patient care services.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Excelsus Statistics

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Excelsus Statistics

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Excelsus Statistics Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Excelsus Statistics

Excelsus Statistics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PPD, Cambrian BioPharma, Medicus Pharma, H.U. Group Holdings and DM Clinical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
CRO providing diversified clinical development services
domain founded_year HQ Location
Medicines and therapies are developed for healthcare applications.
domain founded_year HQ Location
Clinical stage, multi-strategy holding company focused on investing in and accelerating novel therapies in the biotechnology and life sciences industry
domain founded_year HQ Location
Provider of clinical testing, diagnostics, and healthcare services. This entity offers a range of services encompassing laboratory testing and related services, in-vitro diagnostics, healthcare-related services, and research and development. Their activities include supporting research in clinical laboratory medicine, fostering technological advancements, and contributing to the overall progress of medical science and healthcare technology. They also engage in intellectual property activities and have initiatives addressing public health concerns.
domain founded_year HQ Location
Conducts Phase I-IV clinical trials connecting patients with physicians for medical research.
domain founded_year HQ Location
Serves as a contract research organization focused on drug clinical trials.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Excelsus Statistics

Frequently Asked Questions about Excelsus Statistics

When was Excelsus Statistics founded?

Excelsus Statistics was founded in 2014.

Where is Excelsus Statistics located?

Excelsus Statistics is headquartered in Montreal, Canada. It is registered at Montreal, Quebec, Canada.

What does Excelsus Statistics do?

Excelsus Statistics was founded in 2014 and is headquartered in Montreal, Canada. Operations are centered on contract research organization services within the dermatology sector. Clinical development for dermatology drugs is managed, alongside site management and patient recruitment. Focus is placed on supporting pharmaceutical trials through these specialized activities in the North American market.

Who are the top competitors of Excelsus Statistics?

Excelsus Statistics's top competitors include PPD, Cambrian BioPharma and Medicus Pharma.

What products or services does Excelsus Statistics offer?

Excelsus Statistics offers Dermatology Clinical Trials and Aesthetics Research.

Who are Excelsus Statistics's investors?

Excelsus Statistics has 1 investor. Key investors include Innovaderm.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available